Another Switch Study

Lopinavir/ritonavir is a potent boosted PI that has been associated with more adverse metabolic events than some of the newer boosted PIs. Given its favorable lipid profile, boosted atazanavir has been proposed as an effective once-daily alternative. To evaluate the safety and efficacy of switching ... View More